STAT3 inhibits the degradation of HIF-1α by pVHL-mediated ubiquitination
Open Access
- 1 January 2008
- journal article
- Published by Springer Science and Business Media LLC in Experimental & Molecular Medicine
- Vol. 40 (5), 479-85
- https://doi.org/10.3858/emm.2008.40.5.479
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Nur77 upregulates HIF-α by inhibiting pVHL-mediated degradationExperimental & Molecular Medicine, 2008
- Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cellsExperimental & Molecular Medicine, 2005
- STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cellsThe FASEB Journal, 2005
- Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expressionThe FASEB Journal, 2002
- Constitutive activation of Stat3α in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2)Oncogene, 2002
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002
- Constitutive Activation of Stat 3 Oncogene Product in Human Ovarian Carcinoma CellsGynecologic Oncology, 2000
- STATs in oncogenesisOncogene, 2000
- STAT signaling in head and neck cancerOncogene, 2000
- STATs and Gene RegulationScience, 1997